Top-News
Pharmazeutika USA

Corcept Therapeutics Inc. News

Aktie
WKN:  529882 ISIN:  US2183521028 US-Symbol:  CORT
25,82 €
+0,48 €
+1,89%
17.05.24 21:04:51
Handeln Depot/Watchlist
Aktienanzahl *
103,08 Mio.
Marktkapitalisierung *
2,61 Mrd. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 04.01.2024

Corcept Therapeutics Inc. News

02.01.24 - PR Newswire
Thinking about trading options or stock in Exxon Mobil, Amazon.com, Meta Platforms, Enterprise Products Partners, or Corcept Therapeutics?
Thinking about trading options or stock in Exxon Mobil, Amazon.com, Meta Platforms, Enterprise Products Partners, or Corcept Therapeutics? PR Newswire
30.12.22 - PR Newswire
NATIONALLY RANKED ROSEN LAW FIRM Encourages Corcept Therapeutics Incorporated Investors to Inquire About Class Action Investigation - CORT
NATIONALLY RANKED ROSEN LAW FIRM Encourages Corcept Therapeutics Incorporated Investors to Inquire About Class Action Investigation - CORT PR Newswire
27.01.22 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Inc. - CORT
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Inc. - CORT PR Newswire
17.01.22 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Inc. - CORT
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Inc. - CORT PR Newswire
06.01.22 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Inc. - CORT
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Inc. - CORT PR Newswire
13.12.21 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Inc. - CORT
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Inc. - CORT PR Newswire
19.11.20 - PR Newswire
Thinking about buying stock in Aptevo Therapeutics, Electrameccanica Vehicles, AstraZeneca, Corcept Therapeutics, or 22nd Century Group?
Thinking about buying stock in Aptevo Therapeutics, Electrameccanica Vehicles, AstraZeneca, Corcept Therapeutics, or 22nd Century Group? PR Newswire
29.09.20 - PR Newswire
SHAREHOLDER ALERT: Kaskela Law LLC Announces Stockholder Investigation of Corcept Therapeutics Incorporated (CORT) and Encourages Long-Term CORT Stockholders to Contact the Firm
SHAREHOLDER ALERT: Kaskela Law LLC Announces Stockholder Investigation of Corcept Therapeutics Incorporated (CORT) and Encourages Long-Term CORT Stockholders to ...
11.04.19 - PR Newswire
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Corcept Therapeutics Incorporated To Contact The Firm
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Corcept Therapeutics Incorporated To ...
21.03.19 - PR Newswire
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Corcept Therapeutics Incorporated -- CORT
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Corcept Therapeutics Incorporated -- CORT PR Newswire
19.03.19 - PR Newswire
CORT Class Action Alert: Hagens Berman Alerts Corcept Therapeutics (NASDAQ: CORT) Investors to Securities Class Action and May 13, 2019 Lead Plaintiff Deadline
CORT Class Action Alert: Hagens Berman Alerts Corcept Therapeutics (NASDAQ: CORT) Investors to Securities Class Action and May 13, 2019 Lead Plaintiff Deadline PR Newswire
18.03.19 - PR Newswire
Corcept (CORT) Class Action Lawsuit: Bernstein Liebhard LLP Announces A Securities Class Action Lawsuit Against Corcept Therapeutics Incorporated - CORT
Corcept (CORT) Class Action Lawsuit: Bernstein Liebhard LLP Announces A Securities Class Action Lawsuit Against Corcept Therapeutics Incorporated - CORT PR Newswire
15.03.19 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT PR Newswire
05.02.19 - PR Newswire
Investor Alert: Kaplan Fox Investigates Corcept Therapeutics Incorporated
Investor Alert: Kaplan Fox Investigates Corcept Therapeutics Incorporated PR Newswire
20.12.17 - PR Newswire
Interactive Brokers Group Set to Join S&P MidCap 400; Alarm.com Holdings and Corcept Therapeutics to Join S&P SmallCap 600
Interactive Brokers Group Set to Join S&P MidCap 400; Alarm.com Holdings and Corcept Therapeutics to Join S&P SmallCap 600 PR Newswire
02.11.09 - Aktiencheck
Corcept Therapeutics kaufen - Global Biotech Investing
Die Experten von "Global Biotech Investing" raten zum Kauf der Corcept Therapeutics-​Aktie . Die Biotech-​Gesellschaft habe bei Institutionellen 18 Mio. USD eingesammelt, wodurch ...
30.04.07 - Aktiencheck
Corcept Therapeutics vorsichtig abfischen - Global Insider Investing
28.12.06 - Aktiencheck
Corcept Therapeutics im Auge behalten - Global Insider Investing
28.08.06 - Aktiencheck
Corcept Therapeutics Downgrade - Merriman Curhan Ford & Co
Rating-​Update: San Francisco (aktiencheck.de AG) - Die Analysten von Merriman Curhan Ford & Co stufen die Aktie von Corcept Therapeutics von "buy" auf "neutral" zurück. ...
28.08.06 - Aktiencheck
Corcept Therapeutics Downgrade - Thomas Weisel
Rating-​Update: San Francisco (aktiencheck.de AG) - Die Analysten von Thomas Weisel stufen die Aktie von Corcept Therapeutics von "outperform" auf "peer perfrom" zurück. ...

Newssuche

Videos

newspaper
17.05.24 +14,15%
Technical Trading: Gold Long-​Chance
Gold Long Typ: Turbo Open End WKN: VD1G7Y Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »